Ligand Pharmaceuticals
LGND
C$185.34
Share price
-0.67%
Change (1 day)
23.00%
Change (1 year)
Ligand Pharmaceuticals (LGND) Fails to deliver data
Key failure to deliver metrics for Ligand Pharmaceuticals:
- Last SEC data release: 2025-06-30
- Last 15 days FTD volume: C$0.04 M
- Last 3 months FTD volume: C$4.36 M
- Last year FTD volume: C$4.36 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Ligand Pharmaceuticals (LGND) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Ligand Pharmaceuticals (LGND) - since 2013
Volume in USD (price x number of shares), data since 2013Ligand Pharmaceuticals (LGND) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | C$5.18 M | -48.11% |
| 2024 | C$9.99 M | 148.83% |
| 2023 | C$4.01 M | -73.72% |
| 2022 | C$15.27 M | -76.6% |
| 2021 | C$65.29 M | -73.13% |
| 2020 | C$0.24 B | 378.54% |
| 2019 | C$50.77 M | -72.6% |
| 2018 | C$0.18 B | 160.97% |
| 2017 | C$71.02 M | 10.33% |
| 2016 | C$64.37 M | 90.07% |
| 2015 | C$33.86 M | 48.74% |
| 2014 | C$22.76 M | 31.54% |
| 2013 | C$17.3 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Amgen AMGN | C$21.56 M | C$0.29 B | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | N/A | C$0.06 M | 🇺🇸 USA |
 GlaxoSmithKline GSK | C$0.11 B | C$0.38 B | 🇬🇧 UK |
 Merck MRK | C$12.12 M | C$0.17 B | 🇺🇸 USA |
 Pfizer PFE | C$26.37 M | C$0.27 B | 🇺🇸 USA |
 Eli Lilly LLY | C$37.29 M | C$0.20 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | C$11.54 M | C$0.26 B | 🇺🇸 USA |
 Baxter BAX | C$2.02 M | C$43.67 M | 🇺🇸 USA |
 Johnson & Johnson JNJ | C$10.58 M | C$0.12 B | 🇺🇸 USA |